Omeros (OMER) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.39% |
| Dec 31, 2025 | 2.97% |
| Sep 30, 2025 | -0.75% |
| Jun 30, 2025 | -3.17% |
| Mar 31, 2025 | -8.11% |
| Dec 31, 2024 | -7.07% |
| Sep 30, 2024 | -26.11% |
| Jun 30, 2024 | -44.66% |
| Mar 31, 2024 | -15.20% |
| Dec 31, 2023 | -16.57% |
| Sep 30, 2023 | -6.32% |
| Jun 30, 2023 | -5.96% |
| Mar 31, 2023 | -5.22% |
| Dec 31, 2022 | -23.24% |
| Sep 30, 2022 | -58.28% |
| Jun 30, 2022 | -25.68% |
| Mar 31, 2022 | -22.46% |
| Dec 31, 2021 | -29.32% |
| Sep 30, 2021 | -27.04% |
| Jun 30, 2021 | -33.07% |
| Mar 31, 2021 | -18.42% |
| Dec 31, 2020 | -13.39% |
| Sep 30, 2020 | -5.67% |
| Jun 30, 2020 | -11.63% |
| Mar 31, 2020 | -5.72% |
| Dec 31, 2019 | -3.48% |
| Sep 30, 2019 | 8.31% |
| Jun 30, 2019 | 11.52% |
| Mar 31, 2019 | -4.17% |
| Dec 31, 2018 | -5.85% |
| Sep 30, 2018 | -21.41% |
| Jun 30, 2018 | -18.40% |
| Mar 31, 2018 | -22.54% |
| Dec 31, 2017 | -13.39% |
| Sep 30, 2017 | 17.08% |
| Jun 30, 2017 | -7.69% |
| Mar 31, 2017 | -9.53% |
| Dec 31, 2016 | -3.78% |
| Sep 30, 2016 | -14.32% |
| Jun 30, 2016 | -17.17% |
| Mar 31, 2016 | -24.70% |
| Dec 31, 2015 | -16.09% |
| Sep 30, 2015 | -20.84% |
| Jun 30, 2015 | -15.90% |